AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. It operates in three segments. The Aptar Pharma segment sells proprietary dispensing systems, drug delivery systems, sealing solutions and services for the prescription drug, consumer health care, injectables, active material science solutions and digital health market. It also specializes in nasal drug delivery for delivering drugs. The Aptar Beauty segment sells dispensing systems and sealing solutions for the beauty, personal care and home care markets. The Aptar Closures segment sells dispensing systems, sealing solutions and food service trays to the food, beverage, personal care, home care, beauty and healthcare markets. This segment also includes the food protection business and the elastomeric flow-control technology business.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 3.78B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 30.45%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 30.45%.
Undervalued
The company’s latest PB is 3.07, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 57.02M shares, decreasing 13.66% quarter-over-quarter.
Held by ETHSX
Star Investor ETHSX holds 3.55M shares of this stock.